多重耐药菌感染防控制度与措施.pdf
《多重耐药菌感染防控制度与措施.pdf》由会员分享,可在线阅读,更多相关《多重耐药菌感染防控制度与措施.pdf(12页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、1/12 四川省复员退伍军人医院多重耐药菌管理联席会议制度为进一步加强我院多重耐药菌管理,促进医院感染管理科、检验科、药剂科、临床科室多部门协作,做好多重耐药菌医院感染预防与控制工作,根据多重耐药菌感染预防和控制技术指南(试行)等相关要求,建立联席会议制度。1、参加人员医院感染管理科、检验科、药剂科工作人员,各科室医院感染管理组长,必要时邀请医院感染管理委员会主任及相关人员参加。2、时间安排由医院感染管理科牵头,每半年召开一次。3、会议内容(1)各部门对上半年的多重耐药菌管理工作进行总结,介绍各自工作进展情况,用具体的数据说明管理效果和存在的问题。(2)提出解决问题的方案、具体措施及下一阶段的
2、工作重点。4、各部门职责1)医院感染管理科:对多重耐药菌感染患者或定植高危患者进行监测,落实多重耐药菌控制措施:手卫生措施、隔离措施、无菌操作、保洁和环境消毒的监督。负责每季度向全院公布检验科统计结果。2)检验科:及时向临床科室反馈病原学培养结果及药敏报告,对多重耐药菌应做特殊说明;发现耐药菌时书面通知临床科室,电话通知医院感染管理科;每季度统计临床常见分离细菌菌株及其药敏情况,包括全院和重点部门多2/12 重耐药菌的检查变化情况。3)药剂科:及时向检验科通报我院抗菌药物品规变化情况,参与多重耐药菌感染患者会诊,负责抗菌药物临床应用管理,落实抗菌药物的合理使用,根据细菌耐药情况发布抗菌药物的预
3、警信息。4)临床科室:及时、规范采集病原学标本,根据药物敏感试验合理选用或调整抗菌药物;对多重耐药感染或定植患者采取接触隔离措施,及时上报多重耐药菌医院感染病例。多重耐药菌医院感染管理制度及防控措施1、加强多重耐药菌的医院感染管理:当发现有多重耐药菌株流行可能时,医院感染管理科应及时组织调查,临床科室、检验科必须密切协作,并在全院公布感染发生情况,报告医院感染管理委员会、抗菌药物使用指导小组,减少使用可促使这些特殊病原体选择性生长的药物,同时组织人员进行流行病学调查。如出现耐亚胺培南等泛耐药菌株,建议所发生的病区应检查所有的其他病人所用的抗菌药物方案,必要时停用所有可促进这些特殊病原体选择性生
4、长的药物而改用替代药物。2、多重耐药菌的监测:(1)开 展多 重 耐 药菌 的 目 标性 监 测耐甲 氧 西 林金 黄 色 葡萄 球 菌(MRSA)、耐万古霉球菌(VRE)、产超广谱-内酰胺酶(ESBLs)细菌、多重耐药鲍曼不动杆菌、耐碳青霉烯铜绿假单胞菌等(2)早期检出带菌者、严密监测高危人群加强检验科对多重耐药菌的检测,早期检出多重耐药菌感染患者和定植患文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4
5、ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3
6、X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T
7、10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9
8、X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7
9、文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I
10、9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C
11、3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A73/12 者。根据监测结果指导临床对多重耐药菌医院感染的控制工作。从其他医院转入者及易感者的检查,尤其是对年老体弱、有严重基础疾病的免疫力低下患者、接受侵入性检查治疗患者、住院时间长及近期使用广谱、高档抗菌药物治疗的
12、患者等高危人群要严密监测MRSA(耐甲氧西林金葡菌)。3、诊断与报告:主要依赖送检标本的病原学培养结果。临床科室、检验科、医院感染管理科应根据各自的职责做好治疗、消毒、隔离、上报、监测等工作,以防止扩散、流行。(1)临床科室各科室医师应在患者开始抗菌药物治疗前进行微生物学培养,以尽早明确病原菌及药敏结果。获得病原学结果后根据患者临床症状、体征及必要的辅助检查判定系多重耐药菌感染、定植或污染,根据药敏结果合理选用或调整抗菌药物。对于感染及定植患者应及早采取消毒隔离措施,若属于医院感染散发则于 24 小时内及时上报医院感染病例。每天早交接内容中增加科内是否有多重耐药菌感染或定植患者的相关内容,以提
13、醒医务人员采取有效隔离措施;主管医师应在病程中记录多重耐药菌检出、抗菌药物使用及采取隔离措施的情况。重视对具有多重耐药菌感染或定植高危因素患者的监测,及时采集、送检有关标本,必要时开展主动筛查,以及时发现、早期诊断多重耐药菌感染患者和定植患者。临床各科室要关注本院和本科室的细菌耐药监测结果,并根据细菌耐药监测的总结分析报告,合理使用抗菌药物。文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10
14、R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4
15、ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3
16、X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T
17、10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9
18、X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7
19、文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I
20、9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A74/12(2)检验科检验科检出多重耐药菌后,应当及时通知相关临床科室,以便采取有效的治疗和感染控制措施。对检出的多重耐药菌须在检验结果上标注,并填写多重耐药菌MDRO 报告处置表,并向院感染管理科报告当日多重耐药菌检出情况。检验科应
21、不断完善细菌耐药的检测水平,每季度向全院公布一次临床常见分离细菌菌株及其药敏情况、全院多重耐药菌的检出变化情况。(3)医院感染管理科经常下科室了解检验科多重耐药菌检出情况,并查阅病历,对属于感染或定植患者,向该临床科室发放多重耐药菌隔离措施处置表、指导科室多重耐药菌隔离措施执行情况并进行追踪,一旦发现有传播迹象,比如与患者共居一室的其他患者的标本培养出现同一菌种,医院感染管理科应与科室感染控制小组成员合作进行更深入的追踪调查,以防流行的发生。4、加强抗菌药物合理使用管理:严格按照抗菌药物临床应用指导原则和医院抗菌药物临床应用管理办法(试行)要求,严格执行抗菌药物分级使用管理制度和抗菌药物临床应
22、用预警机制。合理使用的前提是要依据病原学药敏结果,同时严格按照权限开处方,联合用药以及使用万古霉素、广谱头孢菌素、碳青霉烯类等必须严格掌握用药指征。避免由于抗菌药物的滥用而导致耐药菌的产生。5、多重耐药菌防控措施:(1)临床科室根据耐药菌检出结果,必须进行接触隔离,由科室负责人监督病区内的MDRO 患者的接触隔离措施的落实情况,感控医师和护士应积极文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9
23、P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3
24、V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ
25、8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10K5T10 HZ8R3X10C3V4 ZW5I9P10R9A7文档编码:CB9X5A10
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 多重 耐药 感染 控制 措施
限制150内